Retapamulin Microdialysis Feasibility Study

Summary

Retapamulin Microdialysis Feasibility Study is a clinical trial^[1].

Key Facts

• Retapamulin Microdialysis Feasibility Study is in the country of United States^[2].
• Retapamulin Microdialysis Feasibility Study's instance of is recorded as clinical trial^[3].
• Retapamulin Microdialysis Feasibility Study's start time is recorded as +2014-04-02T00:00:00Z^[4].
• Retapamulin Microdialysis Feasibility Study's end time is recorded as +2014-05-27T00:00:00Z^[5].
• Retapamulin Microdialysis Feasibility Study's sponsor is recorded as GSK^[6].
• Retapamulin Microdialysis Feasibility Study's main subject is recorded as cellulitis^[7].
• Retapamulin Microdialysis Feasibility Study's number of participants is recorded as {'unit': '1', 'amount': '+3'}^[8].
• Retapamulin Microdialysis Feasibility Study's title is recorded as A Study to Evaluate the Feasibility of Microdialysis to Determine Skin Concentrations of Retapamulin in Healthy Volunteers^[9].
• Retapamulin Microdialysis Feasibility Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Retapamulin Microdialysis Feasibility Study's ClinicalTrials.gov ID is recorded as NCT01812382^[11].
• Retapamulin Microdialysis Feasibility Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+55'}^[12].
• Retapamulin Microdialysis Feasibility Study's research intervention is recorded as retapamulin^[13].
• Retapamulin Microdialysis Feasibility Study's clinical trial phase is recorded as phase I clinical trial^[14].
• Retapamulin Microdialysis Feasibility Study's research site is recorded as GSK^[15].
• Retapamulin Microdialysis Feasibility Study's study type is recorded as interventional study^[16].